Intermediate-high dose cytarabine consolidation therapy in younger adults with acute myeloid leukemia and favorable-intermediate cytogenetic risk: a retrospective study of 124 patients in a single Chinese hospital.
10.3760/cma.j.issn.0253-2727.2019.05.016
- VernacularTitle:中大剂量阿糖胞苷巩固治疗细胞遗传学低中危的年轻急性髓系白血病:124例单中心回顾性分析
- Author:
Yi ZHANG
1
;
Jie Jing QIAN
;
Lei WANG
;
Wen Juan YU
;
Li Ping MAO
;
Hong Yan TONG
;
Hai Tao MENG
;
Wen Bin QIAN
;
Jie JIN
Author Information
1. The First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;
Consolidation Chemotherapy;
Cytarabine;
Cytogenetics;
Humans;
Leukemia, Myeloid, Acute/drug therapy*;
Remission Induction;
Retrospective Studies;
Treatment Outcome
- From:
Chinese Journal of Hematology
2019;40(5):429-431
- CountryChina
- Language:Chinese
